How do you manage TTFields for a patient with glioblastoma in the setting of disease progression?

Topics: Radiation Oncology • Neuro-Oncology • Neurology

Do you routinely discontinue the device or continue if they are otherwise tolerating the treatment well?

Answer from: at Academic Institution

Continuation of Tumor Treating Field (TTF) therapy at progression is an individualized decision for each patient.In the EF-14 trial upon which TTF was approved for newly diagnosed GBM after chemoradiotherapy, TTF was able to be continued until second progression. In this study, 18% more patients wer...

Comments

Radiation Oncologist at Firelands Regional Medical Center
Agree, individualized decision. Typically, I try t...

Related Questions